文献速递流行病学与生物统计医学人工智能与信息学临床试验与 GCP

谁受益?利用贝叶斯方法在适应性试验中揭示隐藏的治疗效应异质性:一项系统综述

Who benefits? Uncovering hidden heterogeneity of treatment effects in adaptive trials using Bayesian methods: a systematic review.
PubMed 文献 · Trials · 2025-11-25

该系统综述检索MEDLINE、Embase等数据库,纳入7项开发贝叶斯方法以在适应性临床试验设计中检测未知治疗效应异质性的原创研究。这些方法在模拟研究中常显示亚组检测、效率或把握度优于非贝叶斯对照,但均未用真实试验数据验证,可重复性有限,且无研究明确将方法定位为解决治疗结局不平等。

要点

  • 贝叶斯方法包括随机划分模型、空间模型、降维逻辑回归、机器学习分类器适应性随机化及适应性富集或平台设计。
  • 模拟研究中这些方法常显示亚组检测、效率或把握度优于非贝叶斯对照,但无一使用真实试验数据测试。
  • 仅最近三项研究提供分析代码,可重复性总体有限;无研究明确将方法定位为解决亚组治疗结局不平等。

核心结论

  • 少量基于模拟的研究展示了贝叶斯方法在适应性临床试验中检测治疗效应异质性的初步但有望的方向。
  • 这些方法显示有潜力增强试验的适应性、可扩展性和包容性,但当前证据仍有限且很大程度上是概念性的。
  • 未来方法学开发需纳入公平性视角,并更重视实证验证和开放科学实践,以确定其在推进公平临床研究中的实际价值。

研究设计与样本

  • 系统综述,检索MEDLINE、Embase和其他数据库,纳入开发贝叶斯方法以在适应性临床试验设计中检测未知治疗效应异质性的原创研究。
  • 共筛选2826条记录,最终7项研究符合纳入标准。
  • 基于设计特征、统计方法、操作特性、可重复性以及是否明确考虑公平相关因素对纳入研究进行综述和综合。

主要发现

  • 贝叶斯方法包括随机划分模型、空间模型、带降维的逻辑回归、使用机器学习分类器的适应性随机化,以及纳入模型平均或潜在亚组估计的适应性富集或平台设计。
  • 在模拟研究中,这些方法常显示亚组检测、效率或把握度相对于非贝叶斯对照有所改善。
  • 无一方法使用真实世界试验数据进行测试。
  • 可重复性总体有限,仅最近三项研究提供分析代码。
  • 无研究明确将其方法定位为解决不同人群亚组治疗结局不平等的工具。

关键数值与推荐

  • 公平性考虑包括研究是否纳入与代表性不足人群相关的变量(如年龄、性别、种族/民族或地理),是否检查交叉亚组效应,或是否明确将方法定位为解决健康差异的工具。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 纳入研究数量少(7项)且均为基于模拟的研究。
  • 当前证据仍有限且很大程度上是概念性的。
  • 可重复性总体有限,仅最近三项研究提供分析代码。
  • 无研究明确将方法定位为解决治疗结局不平等。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Adaptive clinical trials increasingly aim to detect heterogeneity of treatment effect (HTE) to guide personalized care. However, most adaptive designs rely on predefined subgroups and are limited in their ability to uncover unknown or complex sources of HTE. Bayesian statistical methods offer a flexible alternative, enabling real-time learning and adaptation within trials. This review evaluates Bayesian methods used to detect hidden HTE in adaptive clinical trials, with attention to their methodological innovations, operating characteristics, and consideration of equity and inclusion in trial design. METHODS: We conducted a systematic search of MEDLINE, Embase, and other databases to identify original studies that developed Bayesian methods for detecting unknown HTE within adaptive clinical trial designs. Eligible studies were reviewed and synthesized based on design features, statistical methodology, operating characteristics, reproducibility, and whether equity-related factors were explicitly considered. Equity considerations included whether studies incorporated variables related to underrepresented populations-such as age, sex, race/ethnicity, or geography-examined intersectional subgroup effects, or explicitly framed their methods as tools to address health disparities. RESULTS: Of 2826 screened records, seven studies met inclusion criteria. Bayesian methods included random partition models, spatial models, logistic regression with dimension reduction, adaptive randomization using machine learning classifiers, and adaptive enrichment or platform designs incorporating model averaging or latent subgroup estimation. In simulation studies, these methods often showed improvements in subgroup detection, efficiency, or power relative to non-Bayesian comparators. None were tested using real-world trial data. Reproducibility was limited overall, with analytic code only available for the three most recent studies. Notably, none explicitly framed their methods as tools to address inequities in treatment outcomes across population subgroups. CONCLUSIONS: The small number of simulation-based studies illustrates preliminary but promising directions for applying Bayesian methods to detect HTE in adaptive clinical trials. While these approaches demonstrate potential to enhance trial adaptability, scalability, and inclusiveness, current evidence remains limited and largely conceptual. Incorporating an equity lens into future methodological development, alongside greater emphasis on empirical validation and open science practices, will be essential to determine their practical value in advancing equitable clinical research.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Giblon R, Gao C, Liu K, et al. Who benefits? Uncovering hidden heterogeneity of treatment effects in adaptive trials using Bayesian methods: a systematic review. Trials. 2025. PMID: 41291767. doi:10.1186/s13063-025-09291-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。